Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the market grown over the years?

The size of the sugar-based excipients market has been showing consistent growth in the last few years. The market is set to expand from $1.43 billion in 2024 to reach $1.50 billion in 2025, with a compound annual growth rate of 4.5%. Factors such as the expansion of the pharmaceutical industry, growing demand for pediatric and geriatric prescription formulations, rising incidence of chronic illnesses, enhanced use of nutraceuticals, alongside the need for improved solubility and stability, have contributed to the past growth.

What Is the forecasted market size and growth rate for the market?

Anticipation surrounds the market of sugar-based excipients as a consistent growth is forecasted in coming years. By 2029, the market value is expected to elevate up to $1.76 billion, progressing at a compound annual growth rate (CAGR) of 4.1%. The growth predictors for the anticipated period include the escalating demand for oral solid dosage forms, expansion of the nutraceutical sectors, increasing implementation of sugar-based excipients in pediatric and geriatric medicines, higher occurrence of chronic illnesses and the corresponding need for drugs, and the growing elderly population. Future trends to watch out for include the progression in functional excipients, a drift towards non-GMO and natural components, technological evolution, advancements in the domain of orally disintegrating tablets (ODTs), and the incorporation of sugar alcohols.

Get your market report here!

https://www.thebusinessresearchcompany.com/report/sugar-based-excipients-global-market-report

What main drivers are fueling expansion in the market?

The anticipated surge of expansion in the sugar-based excipients market is linked to the increasing trend towards pharmaceuticals. The pharmaceutical industry, dedicated to the research, generation, and promotion of health-boosting drugs, finds its demand escalating due to the need for groundbreaking treatments, advancements in medicinal development technologies, and the worldwide rise in healthcare requirements. Sugar-based excipients play a crucial role in pharmaceuticals, serving as fillers, binders, and stabilizers that enhance medication formulation, taste, and bioavailability. As an illustration, in June 2023, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based association that champions the pharmaceutical industry, showed that total pharmaceutical production in Europe reached $384,200 million (€340,000 million) in 2022. This was a roughly 4.95% increase from the previous year’s 366,267 million (€323,950 million). Hence, the burgeoning interest in pharmaceuticals is fueling the expansion of the sugar-based excipients market.

What key areas define the segmentation of the global Market?

The sugar-based excipients market covered in this report is segmented –

1) By Product: Actual Sugar, Artificial Sweeteners, Sugar Alcohol

2) By Dosage Form: Liquid Dosage Forms, Semi-Solid Dosage Forms, Solid Dosage Forms

3) By Application: Diluents, Fillers, Tonicity Agents, Flavoring Agents

4) By End User: Pharmaceutical Industry, Food And Beverage Industry, Cosmetics And Personal Care Industry

Subsegments:

1) Actual Sugar: Sucrose, Lactose, Dextrose, Fructose, Other Actual Sugars

2) Artificial Sweeteners: Aspartame, Saccharin, Sucralose, Acesulfame K, Other Artificial Sweeteners

3) Sugar Alcohol: Mannitol, Sorbitol, Xylitol, Maltitol, Other Sugar Alcohols

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21291&type=smp

What are the top market players propelling the growth of the industry?

Major companies operating in the sugar-based excipients market are Cargill Incorporated, Archer Daniels Midland Company, Associated British Foods PLC, DuPont de Nemours Inc., IFF Pharmaceuticals Solutions, Ingredion Incorporated, Tereos S.A., Roquette Frères S.A., IMCD N.V., The Lubrizol Corporation, Ashland Global Holdings Inc., Tate & Lyle PLC, Colorcon Inc., DFE Pharma, Emilio Castelli S.R.L., Pfanstiehl Inc., Meggle AG, Scope Ingredients Pvt. Ltd., Citron Scientific, MB Sugars & Pharmaceuticals

What are the key trends shaping the future of the market?

Big players in the sugar-based excipients market are launching groundbreaking products, like next-gen mannitol offerings, to bolster drug constancy, increase solubility, and refine formulation efficacy for pharmaceutical utilization. Advanced versions of mannitol, the next-gen mannitol products, are made to elevate drug steadiness, boost solubility, and amend tablet compression, augmenting pharmaceutical output. For example, Roquette Freres, a French food company, unveiled PEARLITOL CR-H and PEARLITOL 200 GT in October 2022, both are advanced mannitol-based excipients meant for direct compression in medication formulations. These new introductions not only amplify tablet manageability, controlled release, and rapid production but provide innovative solutions for prevailing medication formulation dilemmas.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21291

What regions are dominating the market growth?

North America was the largest region in the sugar-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sugar-based excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Insulin Biosimilars Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-biosimilars-global-market-report

Insulin Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Non-injectable Insulin Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: